Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 149 of 1,261
  1. US 11851449

    Heterocyclic amide compounds having an RORvt inhibitory action

    Takeda Pharmaceutical Company Limited Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  2. US 11850225

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    AMNEAL PHARMACEUTICALS LLC Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  3. US 11851451

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  4. US 11851443

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  5. US 11850247

    Antiviral compounds

    Regents of the University of Minnesota Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  6. US 11851677

    Composition and methods for inducing myeloid suppressive cells and use thereof

    Fate Therapeutics, Inc. Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  7. US 11850269

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Finch Therapeutics Holdings LLC Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  8. US 11850229

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  9. US 11851498

    Anti-CD276 antibodies (B7H3)

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  10. US 11851655

    Compositions and methods for modulating apolipoprotein (a) expression

    Ionis Pharmaceuticals, Inc. Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  11. US 11851653

    Materials and methods for treatment of alpha-1 antitrypsin deficiency

    CRISPR THERAPEUTICS AG Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  12. US 11851440

    Modulators of eukaryotic initiation factor 2B, compositions and methods

    DENALI THERAPEUTICS INC. Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  13. US 11850236

    Method for inhibiting Zika virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  14. US 11851479

    Methods and compositions for pertussis diagnosis

    DXDISCOVERY, INC. Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  15. US 11851490

    Methods and compositions for treating, inhibiting, and/or preventing heterotopic ossification

    Northwestern University Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  16. US 11850243

    Dihydropyridine compositions and methods for treating neurological disorders

    Cavalon Therapeutics, Inc. Β· Granted Dec 26, 2023 Β· Expires Dec 21, 2043

    granted
  17. CA 3259417

    DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT LE RÉCEPTEUR DES LYMPHOCYTES T

    ABLYNX NV [BE] Β· Granted Dec 21, 2023 Β· Expires Dec 16, 2043

    granted
  18. US 11845747

    Ester and carbonate pyrimidine compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  19. US 11845752

    Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B

    Aligos Therapeutics, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  20. US 11844857

    Treating gynecological malignancies with deployable implants

    Covidien LP Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  21. US 11844867

    Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  22. US 11844843

    Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

    Dyne Therapeutics, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  23. US 11845727

    Aldehyde and ketone derivatives of psilocybin and methods of using

    Enveric Biosciences Canada Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  24. US 11844841

    Dosing regimens and related compositions and methods

    Apellis Pharmaceuticals, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.